Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 - Cai, W; Ramdas, M; Zhu, L (Proc Natl Acad Sci U S A, 2012)
et al.